Acrc Arizona Clinical Research Center — research payments reported

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$225	1
2021	Research	$26,692	42
2020	Research	$5,610	8

Breakdown

Who paid Research payments · program years 2020–2023

EMD Serono, Inc. $16,351 28 payments
Takeda Pharmaceuticals U.S.A., Inc. $15,952 22 payments
Alnylam Pharmaceuticals Inc. $225 1 payment

Studies the money was for Research payments · program years 2020–2023

A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0011359C in subjects with metastatic or locally advanced solid tumors with expansion to selected indications. $16,351 28 payments
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Tak-079 in Patients With Persistent/Chronic Primary Immune Thrombocytopenia $15,952 22 payments
#N/A $225 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.